| |
| Business Strategy: |
| Feron identifies products and puts them under clinical trials at an early stage checking for efficacy in patients. At the appropriate stage of clinical development, Feron obtains the relevant regulatory approvals and market the product. Feron applies its strategies accordingly as: |
|
- Promoting its own product candidates
- Co-developing and promoting product candidates in collaboration
- Assisting strategic partners in product lifecycle management
|
| |
| Business Model: |
| Feron maximizes the efficiency of its pharmaceutical development operation by outsourcing manufacturing and later stage clinical development activities to partner companies with particular expertise in these areas. This strategy allows Feron to focus its human and capital resources. These operations include the generation of new product candidates and the servicing of corporate collaborations with major partners for the co-promotion of new products. |
| |
| Collaborations: |
| Feron is India’s sole marketing and distributor for Haidylena Industries, Egypt. Haidylena manufactures world class Polysulfone dialysers. Please read products for more information. |
| Strategic Alliances: |
- Partnerships that involve improving the partner's proprietary product
- Partnerships that involve assisting partners in product lifecycle management
- Partnerships that involve out licensing our internal product candidates
- Partnerships that involve co-developing product candidates
|
| |
